Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERON PHARMACEUTICALS Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 474.75 M 766.46 M 459.28 M 298.54 M 295.98 M
    Net Receivables 35.21 M 18.32 M 7.49 M 36.52 M 43.10 M
    Total Inventories 0.00 0.00 0.00 2.90 M 3.23 M
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses — — — — —
    Other Current Assets 11.48 M 13.05 M 3.22 M 3.42 M 1.64 M
    Current Assets Total 521.44 M 797.83 M 469.98 M 341.39 M 343.96 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 52.71 M 79.82 M 63.58 M 18.11 M 52.93 M
    Property, Plant & Equipment Net 87.85 M 58.30 M 49.35 M 60.54 M 71.24 M
    Property, Plant & Equipment Gross 187.14 M 154.78 M 136.96 M 150.63 M 148.52 M
    Accumulated Depreciation 99.28 M 96.48 M 87.61 M 90.10 M 77.28 M
    Other Assets 8.03 M 303,000.00 2.17 M 3.46 M 4.98 M
    Deferred Charges — — — — —
    Tangible Other Assets 8.03 M 303,000.00 3.46 M 4.98 M —
    Intangible Other Assets — — — — —
    Total Assets 670.04 M 936.26 M 585.09 M 423.50 M 473.11 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 200.00 M 0.00 0.00 0.00
    Accrued Payroll 5.95 M 14.51 M 9.93 M 10.71 M 7.97 M
    Income Taxes Payable — — — — —
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 71.46 M 61.02 M 30.73 M 25.44 M 21.76 M
    Current Liabilities Total 83.67 M 283.66 M 45.01 M 40.36 M 34.14 M
    Long Term Debt 0.00 0.00 200.00 M 200.00 M 200.00 M
    Provision for Risks & Charges — — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 162.42 M 192.33 M 123.45 M 69.14 M 56.43 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 5.09 M 0.00 0.00 0.00 0.00
    Total Liabilities 251.19 M 475.99 M 368.47 M 309.50 M 290.56 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 418.85 M 460.27 M 216.62 M 114.00 M 182.54 M
    Common Stock 80,000.00 79,000.00 65,000.00 56,000.00 56,000.00
    Capital Surplus 1.29 B 1.25 B 904.41 M 700.01 M 675.39 M
    Revaluation Reserves — — — — —
    Other Appropriated Reserves 0.00 0.00 0.00 -315,000.00 -2.30 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -875.93 M -793.22 M -687.62 M -585.28 M -489.83 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -114,000.00 170,000.00 -231,000.00 -470,000.00 -769,000.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 670.04 M 936.26 M 585.09 M 423.50 M 473.11 M
    Common Shares Outstanding 79.89 M 78.85 M 65.40 M 56.44 M 55.86 M